🚀 VC round data is live in beta, check it out!
- Public Comps
- Fangzhou
Fangzhou Valuation Multiples
Discover revenue and EBITDA valuation multiples for Fangzhou and similar public comparables like 1-800-Flowers.com, Oponeo, Nelly Group, Kogan.com and more.
Fangzhou Overview
About Fangzhou
Fangzhou Inc is a online chronic disease management platform in China. It has focus on chronic disease management to address the needs of patients with chronic diseases, such as hypertension, cardiovascular and respiratory chronic diseases. The company provide comprehensive medical services and online retail pharmacy services through Jianke Platform. The principal segment of the group are online retail pharmacy services, comprehensive medical services, Wholesale and customized content and marketing solutions. Key revenue is generated from Online retail pharmacy services.
Founded
2019
HQ

Employees
488
Website
Financials (LTM)
EV
$212M
Fangzhou Financials
Fangzhou reported last 12-month revenue of $561M and EBITDA of $6M.
In the same LTM period, Fangzhou generated $92M in gross profit, $6M in EBITDA, and $3M in net income.
Revenue (LTM)
Fangzhou P&L
In the most recent fiscal year, Fangzhou reported revenue of $397M and EBITDA of ($121M).
Fangzhou expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | $561M | XXX | $397M | XXX | XXX | XXX |
| Gross Profit | $92M | XXX | $76M | XXX | XXX | XXX |
| Gross Margin | 16% | XXX | 19% | XXX | XXX | XXX |
| EBITDA | $6M | XXX | ($121M) | XXX | XXX | XXX |
| EBITDA Margin | 1% | XXX | (31%) | XXX | XXX | XXX |
| EBIT Margin | 1% | XXX | (28%) | XXX | XXX | XXX |
| Net Profit | $3M | XXX | ($125M) | XXX | XXX | XXX |
| Net Margin | 0% | XXX | (32%) | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Fangzhou Stock Performance
Fangzhou has current market cap of $253M, and enterprise value of $212M.
Market Cap Evolution
Fangzhou's stock price is $0.18.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $212M | $253M | 3.0% | XXX | XXX | XXX | $-0.09 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialFangzhou Valuation Multiples
Fangzhou trades at 0.4x EV/Revenue multiple, and 37.9x EV/EBITDA.
EV / Revenue (LTM)
Fangzhou Financial Valuation Multiples
As of April 18, 2026, Fangzhou has market cap of $253M and EV of $212M.
Equity research analysts estimate Fangzhou's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Fangzhou has a P/E ratio of 94.8x.
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $253M | XXX | $253M | XXX | XXX | XXX |
| EV (current) | $212M | XXX | $212M | XXX | XXX | XXX |
| EV/Revenue | 0.4x | XXX | 0.5x | XXX | XXX | XXX |
| EV/EBITDA | 37.9x | XXX | (1.7x) | XXX | XXX | XXX |
| EV/EBIT | 69.7x | XXX | (1.9x) | XXX | XXX | XXX |
| EV/Gross Profit | 2.3x | XXX | 2.8x | XXX | XXX | XXX |
| P/E | 94.8x | XXX | (2.0x) | XXX | XXX | XXX |
| EV/FCF | — | XXX | 92.7x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Fangzhou Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


Fangzhou Margins & Growth Rates
Fangzhou's revenue in the last 12 month grew by 33%.
Fangzhou's revenue per employee in the last FY averaged $0.8M, while opex per employee averaged $0.4M for the same period.
Fangzhou's rule of 40 is 34% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Fangzhou's rule of X is 82% (created by Bessemer, rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Fangzhou Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 33% | XXX | 29% | XXX | XXX | XXX |
| EBITDA Margin | 1% | XXX | (31%) | XXX | XXX | XXX |
| EBITDA Growth | 136% | XXX | (103%) | XXX | XXX | XXX |
| Rule of 40 | — | XXX | 34% | XXX | XXX | XXX |
| Bessemer Rule of X | — | XXX | 82% | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $0.8M | XXX | XXX | XXX |
| Opex per Employee | — | XXX | $0.4M | XXX | XXX | XXX |
| S&M Expenses to Revenue | 11% | XXX | 13% | XXX | XXX | XXX |
| G&A Expenses to Revenue | 4% | XXX | 34% | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 47% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Fangzhou Public Comps
See public comps and valuation multiples for other Consumer E-commerce and Pharmacies comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Fangzhou | XXX | XXX | XXX | XXX | XXX | XXX |
| 1-800-Flowers.com | XXX | XXX | XXX | XXX | XXX | XXX |
| Oponeo | XXX | XXX | XXX | XXX | XXX | XXX |
| Nelly Group | XXX | XXX | XXX | XXX | XXX | XXX |
| Kogan.com | XXX | XXX | XXX | XXX | XXX | XXX |
| Scroll | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Fangzhou M&A Activity
Fangzhou acquired XXX companies to date.
Last acquisition by Fangzhou was on XXXXXXXX, XXXXX. Fangzhou acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Fangzhou
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialFangzhou Investment Activity
Fangzhou invested in XXX companies to date.
Fangzhou made its latest investment on XXXXXXXX, XXXXX. Fangzhou invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Fangzhou
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Fangzhou
| When was Fangzhou founded? | Fangzhou was founded in 2019. |
| Where is Fangzhou headquartered? | Fangzhou is headquartered in China. |
| How many employees does Fangzhou have? | As of today, Fangzhou has over 488 employees. |
| Who is the CEO of Fangzhou? | Fangzhou's CEO is Fangmin Xie. |
| Is Fangzhou publicly listed? | Yes, Fangzhou is a public company listed on HKEX. |
| What is the stock symbol of Fangzhou? | Fangzhou trades under 06086 ticker. |
| When did Fangzhou go public? | Fangzhou went public in 2024. |
| Who are competitors of Fangzhou? | Fangzhou main competitors are 1-800-Flowers.com, Oponeo, Nelly Group, Kogan.com. |
| What is the current market cap of Fangzhou? | Fangzhou's current market cap is $253M. |
| What is the current revenue of Fangzhou? | Fangzhou's last 12 months revenue is $561M. |
| What is the current revenue growth of Fangzhou? | Fangzhou revenue growth (NTM/LTM) is 33%. |
| What is the current EV/Revenue multiple of Fangzhou? | Current revenue multiple of Fangzhou is 0.4x. |
| Is Fangzhou profitable? | Yes, Fangzhou is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Fangzhou? | Fangzhou's last 12 months EBITDA is $6M. |
| What is Fangzhou's EBITDA margin? | Fangzhou's last 12 months EBITDA margin is 1%. |
| What is the current EV/EBITDA multiple of Fangzhou? | Current EBITDA multiple of Fangzhou is 37.9x. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.